{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:10:20Z","timestamp":1762503020312,"version":"build-2065373602"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,23]],"date-time":"2020-01-23T00:00:00Z","timestamp":1579737600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000521","name":"Canadian Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000521","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009812","name":"Princess Margaret Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009812","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.ctro.2020.01.003","type":"journal-article","created":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T16:40:16Z","timestamp":1580229616000},"page":"69-76","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Durable therapeutic gain despite competing mortality in long-term follow-up of a randomized hyperfractionated radiotherapy trial for locally advanced head and neck cancer"],"prefix":"10.1016","volume":"21","author":[{"given":"Brian","family":"O'Sullivan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shao","family":"Hui Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Keane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8402-9235","authenticated-orcid":false,"given":"Jie","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Waldron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Gullane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei-Fei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Padraig","family":"Warde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Payne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3247-8362","authenticated-orcid":false,"given":"Li","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Cummings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctro.2020.01.003_b0005","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0140-6736(06)69121-6","article-title":"Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis","volume":"368","author":"Bourhis","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ctro.2020.01.003_b0010","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/028418699431528","article-title":"Benefits of accelerated hyperfractionation for head and neck cancer","volume":"38","author":"Cummings","year":"1999","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ctro.2020.01.003_b0015","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0167-8140(99)00042-0","article-title":"Fractionation sensitivities and dose-control relations of head and neck carcinomas: analysis of the randomized hyperfractionation trials","volume":"51","author":"Stuschke","year":"1999","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2020.01.003_b0020","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3109\/02841868809090333","article-title":"The hazard of accelerated tumor clonogen repopulation during radiotherapy","volume":"27","author":"Withers","year":"1988","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ctro.2020.01.003_b0025","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0167-8140(92)90226-K","article-title":"The effect of increasing the treatment time beyond three weeks on the control of T2 and T3 laryngeal cancer using radiotherapy","volume":"24","author":"Slevin","year":"1992","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2020.01.003_b0030","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0360-3016(83)90290-0","article-title":"The influence of the number of fractions and of overall treatment time on local control and late complication rate in squamous cell carcinoma of the larynx","volume":"9","author":"Maciejewski","year":"1983","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2020.01.003_b0035","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0140-6736(03)14361-9","article-title":"Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial","volume":"362","author":"Overgaard","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ctro.2020.01.003_b0040","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.radonc.2007.09.010","article-title":"Five year results of a randomized trial comparing hyperfractionated to conventional radiotherapy over four weeks in locally advanced head and neck cancer","volume":"85","author":"Cummings","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2020.01.003_b0045","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.radonc.2008.02.014","article-title":"A dose escalation study of hyperfractionated accelerated radiation delivered with integrated neck surgery (HARDWINS) for the management of advanced head and neck cancer","volume":"87","author":"Waldron","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2020.01.003_b0050","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0167-8140(97)00117-5","article-title":"Accelerated fractionation: what is the price for speeding?","volume":"44","author":"Ang","year":"1997","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2020.01.003_b0055","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/0360-3016(91)90722-G","article-title":"Experience with CHART","volume":"21","author":"Saunders","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2020.01.003_b0060","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0167-8140(00)00139-0","article-title":"Randomized clinical trial on 7-day-continuous accelerated irradiation (CAIR) of head and neck cancer - report on 3-year tumour control and normal tissue toxicity","volume":"55","author":"Skladowski","year":"2000","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2020.01.003_b0065","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.ijrobp.2006.05.026","article-title":"Continuous accelerated 7-days-a-week radiotherapy for head-and-neck cancer: long-term results of phase III clinical trial","volume":"66","author":"Skladowski","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2020.01.003_b0070","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0167-8140(97)00079-0","article-title":"Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial","volume":"44","author":"Horiot","year":"1997","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2020.01.003_b0075","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0167-8140(97)01944-0","article-title":"A randomised trial of accelerated versus conventional radiotherapy in head and neck cancer","volume":"43","author":"Jackson","year":"1997","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2020.01.003_b0080","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1002\/cncr.28588","article-title":"Causes of death in long-term survivors of head and neck cancer","volume":"120","author":"Baxi","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.ctro.2020.01.003_b0085","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1200\/JCO.2012.43.6097","article-title":"Long-term results of RTOG 91\u201311: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer","volume":"31","author":"Forastiere","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctro.2020.01.003_b0090","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.ijrobp.2012.05.008","article-title":"Long-term follow-up of the RTOG 9501\/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck","volume":"84","author":"Cooper","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2020.01.003_b0095","unstructured":"ICRU: Dose, specification for reporting external beam therapy with photons and electrons ICRU Report 29 1978 International Commission on Radiation Units and Measurement Bethesda, MD."},{"key":"10.1016\/j.ctro.2020.01.003_b0100","unstructured":"H. Thames J. Hendry Fractionation in Radiotherapy 1987 Taylor and Francis."},{"key":"10.1016\/j.ctro.2020.01.003_b0105","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0360-3016(01)01613-3","article-title":"The benefits and pitfalls of ipsilateral radiotherapy in carcinoma of the tonsillar region","volume":"51","author":"O'Sullivan","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2020.01.003_b0110","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","article-title":"Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)","volume":"31","author":"Cox","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2020.01.003_b0115","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1002\/sim.2655","article-title":"Analysing and interpreting competing risk data","volume":"26","author":"Pintilie","year":"2007","journal-title":"Stat Med"},{"key":"10.1016\/j.ctro.2020.01.003_b0120","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/0360-3016(95)00228-Q","article-title":"Local control of carcinoma of the tonsil by radiation therapy: an analysis of patterns of fractionation in nine institutions","volume":"33","author":"Withers","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2020.01.003_b0125","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.oraloncology.2014.03.009","article-title":"25 year survival outcomes for squamous cell carcinomas of the head and neck: population-based outcomes from a Canadian province","volume":"50","author":"Tiwana","year":"2014","journal-title":"Oral Oncol"},{"key":"10.1016\/j.ctro.2020.01.003_b0130","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ijrobp.2013.12.027","article-title":"Final results of local-regional control and late toxicity of RTOG 9003: a randomized trial of altered fractionation radiation for locally advanced head and neck cancer","volume":"89","author":"Beitler","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2020.01.003_b0135","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1245\/s10434-014-3951-8","article-title":"Cancer-specific mortality and competing mortality in patients with head and neck squamous cell carcinoma: a competing risk analysis","volume":"22","author":"Shen","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ctro.2020.01.003_b0140","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1002\/hed.25559","article-title":"Competing mortality in oropharyngeal carcinoma according to human papillomavirus status","volume":"41","author":"Lop","year":"2019","journal-title":"Head Neck"},{"key":"10.1016\/j.ctro.2020.01.003_b0145","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0140-6736(92)90218-R","article-title":"Biological basis of radiation therapy for cancer","volume":"339","author":"Withers","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.ctro.2020.01.003_b0150","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13014-018-1040-z","article-title":"The alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies","volume":"13","author":"van Leeuwen","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ctro.2020.01.003_b0155","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0167-8140(97)00094-7","article-title":"A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer","volume":"44","author":"Dische","year":"1997","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2020.01.003_b0160","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0167-8140(01)00347-4","article-title":"A randomised trial of accelerated and conventional radiotherapy for stage III and IV squamous carcinoma of the head and neck: a Trans-Tasman Radiation Oncology Group Study","volume":"60","author":"Poulsen","year":"2001","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2020.01.003_b0165","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0167-8140(92)90242-M","article-title":"Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy","volume":"25","author":"Horiot","year":"1992","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2020.01.003_b0170","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1093\/annonc\/mdu128","article-title":"Noncancer health events as a leading cause of competing mortality in advanced head and neck cancer","volume":"25","author":"Kwon","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ctro.2020.01.003_b0175","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1200\/JCO.2008.20.9288","article-title":"Predictors of competing mortality in advanced head and neck cancer","volume":"28","author":"Mell","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctro.2020.01.003_b0180","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.otc.2013.04.008","article-title":"Survivorship\u2013competing mortalities, morbidities, and second malignancies","volume":"46","author":"Montero-Miranda","year":"2013","journal-title":"Otolaryngol Clin North Am"},{"key":"10.1016\/j.ctro.2020.01.003_b0185","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1200\/JCO.2011.35.7301","article-title":"Population-based study of competing mortality in head and neck cancer","volume":"29","author":"Rose","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctro.2020.01.003_b0190","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/annonc\/mdu360","article-title":"Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)dagger","volume":"26","author":"Bellera","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ctro.2020.01.003_b0195","first-page":"133","article-title":"Are autopsies useful? Do premorbid findings predict postmortem results in head and neck cancer patients?","volume":"84","author":"Jennings","year":"2002","journal-title":"Ann R Coll Surg Engl"},{"issue":"4","key":"10.1016\/j.ctro.2020.01.003_b0200","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1080\/000164802760057608","article-title":"Clinical review of autopsy cases that succumbed to head and neck malignancies","volume":"122","author":"Sano","year":"2002","journal-title":"Acta Otolaryngol"},{"key":"10.1016\/j.ctro.2020.01.003_b0205","doi-asserted-by":"crossref","first-page":"4096","DOI":"10.1200\/JCO.2007.13.3983","article-title":"Evaluation of early and late toxicities in chemoradiation trials","volume":"25","author":"Bentzen","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctro.2020.01.003_b0210","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S1470-2045(07)70144-4","article-title":"TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group","volume":"8","author":"Trotti","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctro.2020.01.003_b0215","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1158\/1055-9965.EPI-19-0038","article-title":"Incidence and demographic burden of HPV-associated oropharyngeal head and neck cancers in the United States","volume":"28","author":"Mahal","year":"2019","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ctro.2020.01.003_b0220","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.radonc.2012.01.011","article-title":"Effect of smoking on oxygen delivery and outcome in patients treated with radiotherapy for head and neck squamous cell carcinoma\u2013a prospective study","volume":"103","author":"Hoff","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2020.01.003_b0225","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.radonc.2019.02.021","article-title":"The effects of continued smoking in head and neck cancer patients treated with radiotherapy: A systematic review and meta-analysis","volume":"135","author":"Smith","year":"2019","journal-title":"Radiother Oncol"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630820300033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630820300033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:06:16Z","timestamp":1762502776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630820300033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":45,"alternative-id":["S2405630820300033"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2020.01.003","relation":{},"ISSN":["2405-6308"],"issn-type":[{"type":"print","value":"2405-6308"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Durable therapeutic gain despite competing mortality in long-term follow-up of a randomized hyperfractionated radiotherapy trial for locally advanced head and neck cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2020.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}]}}